Italy approves use of two drugs to treat COVID

The Scientific and Technical Committee of the Italian Medicines Agency (Aifa) has authorized the use of two new antiviral drugs, molnupiravir and remdesivir, to treat COVID-19, Report informs via foreign media.

So, these drugs can be used for the treatment of non-hospitalized patients with mild to moderate COVID-19. The medicine will be used at the initial stage of the disease to prevent it from becoming severe.

The use of molnupiravir will begin in Italy on January 4.